Related Experiment Videos
Recent advances on alpha-synuclein cell biology: functions and dysfunctions
1IPMC du CNRS, UMR6097, 660 Route des Lucioles, Sophia Antipolis, 06560, Valbonne, France. acosta@ipmc.cnrs.fr
Current Molecular Medicine
|February 1, 2003
Summary
Alpha-synuclein protein is implicated in both Alzheimer's and Parkinson's diseases. Post-translational modifications of alpha-synuclein may explain its dysfunction in these neurodegenerative conditions.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Alpha-synuclein is a protein found in senile plaques associated with Alzheimer's disease.
- Alpha-synuclein is a key component of Lewy bodies, linked to Parkinson's disease etiology.
- Familial Parkinson's disease cases show mutations in the alpha-synuclein gene.
Purpose of the Study:
- To explore alpha-synuclein as a potential link between Alzheimer's and Parkinson's diseases.
- To review recent advances in understanding alpha-synuclein physiology.
- To focus on post-translational modifications and their impact on alpha-synuclein function.
Main Methods:
- Literature review of recent advances in alpha-synuclein research.
- Focus on post-translational modifications of alpha-synuclein.
- Analysis of how these modifications affect protein function.
Main Results:
- Recent studies suggest post-translational modifications drastically alter alpha-synuclein's biophysical properties.
- These modifications appear to directly modulate alpha-synuclein's normal physiological function.
- Altered alpha-synuclein function is likely involved in Parkinson's disease pathology.
Conclusions:
- Alpha-synuclein may serve as a common factor in neurodegenerative diseases like Alzheimer's and Parkinson's.
- Understanding alpha-synuclein's physiological role and dysfunction is crucial.
- Post-translational modifications are key to understanding alpha-synuclein's role in disease.